论文部分内容阅读
最多见于穹窿部和下1/3处的阴道复发是子宫内膜癌仅用手术治疗后自然预后的一部分;其发生率随手术范围不一可高达10%～12%。推测复发原因可能为手术促使癌细胞脱落、种植或先前微小播散于穹窿部及阴道下部的血管性或淋巴性渗透或栓塞所致。Dobbie、Morris 及其他学者报道,手术后穹窿部位的放疗使该处很少复发。为此,其他学者手术前应用阴道和子宫腔内放疗。作者等认为仍应努力防止阴道下部的复发,术后应尽早地在闭孔处用线性镭疗,近来则用后装技术进行全阴道放疗。在 Sydney-所教学医院的30年经验资料表明,阴道转移的发生可随该术后辅助治疗大大减少。
Most seen in the vault and lower 1/3 of the vaginal recurrence of endometrial cancer is only part of the natural prognosis after surgery; its incidence varies with the surgical range can be as high as 10% to 12%. It is speculated that the cause of the recurrence may be due to surgery to cause cancer cells to fall off, implantation or previous vascular or lymphatic osmosis or embolization that is slightly diffused in the fornix and the vagina. Dobbie, Morris, and others report that radiotherapy at the posterior fornix site rarely relaps there. To this end, other scholars preoperative vaginal and intrauterine radiotherapy. The authors believe that efforts should still be made to prevent the recurrence of the lower part of the vagina, postoperative as soon as possible in the obturator with linear radiotherapy, and later with the post-loading technique for all-vaginal radiotherapy. Thirty years of experience at Sydney-teaching hospitals have shown that the incidence of vaginal metastases can be greatly reduced with this postoperative adjuvant therapy.